Clinical Trials

NCT05622643 | ACTIVE_NOT_RECRUITING

300 participants

OFSEP Very High Definition Cohort

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2023-01-19

Completion:

2027-12-01

Conditions

• Multiple Sclerosis

Interventions

• OTHER

No Results Yet

NCT05601128 | COMPLETED | PHASE3

12 participants

A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2023-01-01

Completion:

2025-04-01

Conditions

• HIV-1-infection
• HIV Infections
• HIV I Infection

Interventions

• DRUG

No Results Yet

NCT05600777 | ACTIVE_NOT_RECRUITING | PHASE3

997 participants

A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-12-05

Completion:

2026-06-10

Conditions

• Cough
• Refractory Chronic Cough

Interventions

• DRUG

No Results Yet

NCT05599191 | COMPLETED | PHASE3

957 participants

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-10-25

Completion:

2025-12-17

Conditions

• Cough
• Refractory Chronic Cough

Interventions

• DRUG

No Results Yet

NCT05598320 | COMPLETED | PHASE2/PHASE3

84 participants

A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2023-03-03

Completion:

2024-08-09

Conditions

• Achondroplasia

Interventions

• DRUG

Results Available

NCT05568550 | RECRUITING | PHASE2

64 participants

Pembro With Radiation With or Without Olaparib

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2023-07-27

Completion:

2027-12-02

Conditions

• Prostate Cancer

Interventions

• BIOLOGICAL
• DRUG
• RADIATION

No Results Yet

NCT05533697 | RECRUITING | PHASE1/PHASE2

361 participants

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-09-01

Completion:

2032-02-18

Conditions

• Advanced Solid Tumors

Interventions

• BIOLOGICAL

No Results Yet

NCT05524597 | RECRUITING | PHASE1

200 participants

Writing About Experiences and Health in Older Adults II

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2023-03-13

Completion:

2026-12-31

Conditions

• Social Psychology

Interventions

• BEHAVIORAL

No Results Yet

NCT05451004 | RECRUITING | PHASE3

510 participants

SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2023-02-10

Completion:

2030-08-30

Conditions

• Oropharyngeal Cancer

Interventions

• OTHER
• RADIATION

No Results Yet

NCT05444504 | RECRUITING | NA

100 participants

Effectiveness and Acceptability of Insertable Devices for Obstetric Fistula Management

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2023-04-15

Completion:

2026-12-31

Conditions

• Obstetric Fistula
• Fistula
• Fistula, Urinary
• Fistula, Vaginal

Interventions

• DEVICE

No Results Yet

NCT05437939 | ACTIVE_NOT_RECRUITING

802 participants

Adverse Outcomes Following Female Genital Fistula Repair

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2022-05-20

Completion:

2026-08-31

Conditions

• Female Genital Fistula
• Incontinence

No Results Yet

NCT05429827 | COMPLETED | NA

23 participants

The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-11-18

Completion:

2024-06-21

Conditions

• Myofascial Trigger Point Pain

Interventions

• OTHER
• DRUG

No Results Yet

NCT05400122 | SUSPENDED | PHASE1

12 participants

Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-09-09

Completion:

2026-12-31

Conditions

• Colorectal Cancer
• Hematologic Malignancy
• Rectum Cancer
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Non Hodgkin Lymphoma
• Myeloproliferative Syndrome
• Plasma Cell Myeloma
• Gastric Cancer
• Esophageal Cancer
• Esophagus Cancer
• Gastric Cancer, Metastatic
• Unresectable Esophageal Cancer
• Metastatic Esophageal Cancer

Interventions

• DRUG

No Results Yet

NCT05388708 | ACTIVE_NOT_RECRUITING

550 participants

ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2021-02-04

Completion:

2027-06-30

Conditions

• Acute Respiratory Distress Syndrome
• Extracorporeal Membrane Oxygenation

Interventions

• DEVICE
• OTHER

No Results Yet

NCT05371808 | RECRUITING

247 participants

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2023-01-27

Completion:

2028-10-01

Conditions

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Interventions

• OTHER

No Results Yet

NCT05363670 | COMPLETED | PHASE2

18 participants

Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-07-28

Completion:

2024-02-02

Conditions

• Asthma

Interventions

• DRUG

Results Available

NCT05361941 | RECRUITING | NA

204 participants

Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2023-08-31

Completion:

2029-12-31

Conditions

• Periprosthetic Joint Infections

Interventions

• DEVICE

No Results Yet

NCT05351593 | RECRUITING | PHASE1/PHASE2

35 participants

Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-06-08

Completion:

2026-12-31

Conditions

• CNS Lymphoma
• Primary Central Nervous System Lymphoma
• Secondary Central Nervous System Lymphoma

Interventions

• DRUG

No Results Yet

NCT05286801 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

86 participants

Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-11-17

Completion:

2030-03-31

Conditions

• Atypical Teratoid/Rhabdoid Tumor
• Epithelioid Sarcoma
• Kidney Medullary Carcinoma
• Malignant Solid Neoplasm
• Poorly Differentiated Chordoma
• Recurrent Atypical Teratoid/Rhabdoid Tumor
• Recurrent Chordoma
• Recurrent Epithelioid Sarcoma
• Recurrent Kidney Medullary Carcinoma
• Recurrent Malignant Solid Neoplasm
• Recurrent Rhabdoid Tumor
• Refractory Atypical Teratoid/Rhabdoid Tumor
• Refractory Chordoma
• Refractory Epithelioid Sarcoma
• Refractory Kidney Medullary Carcinoma
• Refractory Malignant Solid Neoplasm
• Refractory Rhabdoid Tumor
• Rhabdoid Tumor

Interventions

• BIOLOGICAL
• PROCEDURE
• OTHER

No Results Yet

NCT05286736 | ACTIVE_NOT_RECRUITING

50 participants

Neuroplasticity in Parkinson's Disease

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2021-03-01

Completion:

2026-08-31

Conditions

• Parkinson
• Parkinson Disease

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT05286437 | ACTIVE_NOT_RECRUITING | PHASE2

40 participants

Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2023-02-15

Completion:

2026-12-31

Conditions

• Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer

Interventions

• DRUG

No Results Yet

NCT05272319 | COMPLETED

171 participants

Genetic Collection Protocol

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2022-04-06

Completion:

2026-05-27

Conditions

• Liver Diseases

No Results Yet

NCT05248646 | ACTIVE_NOT_RECRUITING | PHASE3

530 participants

Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-03-15

Completion:

2026-05-13

Conditions

• Immunoglobulin A Nephropathy

Interventions

• DRUG

No Results Yet

NCT05241522 | COMPLETED | PHASE1

57 participants

Dosimetry of Tc-99m-Tilmanocept

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2021-08-06

Completion:

2025-06-30

Conditions

• Diabetic Kidney Disease

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT05223322 | ACTIVE_NOT_RECRUITING | NA

80 participants

Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-03-01

Completion:

2026-12-31

Conditions

• Breast Cancer

Interventions

• BEHAVIORAL

No Results Yet

NCT05215197 | RECRUITING | NA

10 participants

Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-01-31

Completion:

2028-12-01

Conditions

• Hearing Loss, Sensorineural

Interventions

• DRUG

No Results Yet

NCT05184816 | RECRUITING | PHASE1

32 participants

A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2021-12-22

Completion:

2027-12-31

Conditions

• Leptomeningeal Metastases

Interventions

• DRUG

No Results Yet

NCT05169970 | ACTIVE_NOT_RECRUITING | PHASE2

222 participants

A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2021-12-09

Completion:

2027-12-31

Conditions

• Prostate Cancer

Interventions

• RADIATION

No Results Yet

NCT05132283 | RECRUITING | NA

20 participants

Urologic Lymphadenectomy in AMIGO

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-04-01

Completion:

2026-08-01

Conditions

• Urologic Cancer
• Lymph Node Metastasis

Interventions

• DEVICE

No Results Yet

NCT05121051 | RECRUITING | PHASE2

135 participants

Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-09-21

Completion:

2027-01-13

Conditions

• Cigarette Smoking-Related Carcinoma

Interventions

• PROCEDURE
• DIETARY_SUPPLEMENT
• DRUG
• OTHER

No Results Yet

NCT05077735 | RECRUITING | PHASE2

32 participants

Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2021-10-11

Completion:

2027-10-15

Conditions

• Diffuse Midline Glioma, H3 K27M-Mutant

Interventions

• RADIATION
• OTHER
• PROCEDURE

No Results Yet

NCT05062317 | RECRUITING | PHASE2

120 participants

ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-04-26

Completion:

2027-02-28

Conditions

• Liver Metastases

Interventions

• DRUG

No Results Yet

NCT05038592 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

64 participants

Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-03-04

Completion:

2027-01-29

Conditions

• Chronic Myelomonocytic Leukemia
• Chronic Myelomonocytic Leukemia-1
• Chronic Myelomonocytic Leukemia-2
• Myelodysplastic/Myeloproliferative Neoplasm

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT05034432 | RECRUITING | PHASE4

100 participants

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-05-27

Completion:

2027-04-30

Conditions

• Arrythmia
• Cardiomyopathies

Interventions

• PROCEDURE
• OTHER

No Results Yet

NCT05027984 | ACTIVE_NOT_RECRUITING | NA

1425 participants

Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2021-06-30

Completion:

2028-03-31

Conditions

• Coronary Artery Disease
• Coronary Disease
• Ischemic Heart Disease

Interventions

• DEVICE

No Results Yet

NCT05009862 | COMPLETED | PHASE4

60 participants

The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2022-04-19

Completion:

2025-07-01

Conditions

• Peripheral Arterial Disease

Interventions

• DRUG

No Results Yet

NCT04995523 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

212 participants

A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2021-09-14

Completion:

2026-08-28

Conditions

• Non-Small-Cell Lung Carcinoma

Interventions

• DRUG

No Results Yet

NCT04964934 | ACTIVE_NOT_RECRUITING | PHASE3

315 participants

Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2021-06-30

Completion:

2025-06-30

Conditions

• ER-Positive HER2-Negative Breast Cancer

Interventions

• DRUG

No Results Yet

NCT04950075 | ACTIVE_NOT_RECRUITING | PHASE2

206 participants

Study of INBRX-109 in Conventional Chondrosarcoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2021-09-23

Completion:

2025-09-30

Conditions

• Conventional Chondrosarcoma

Interventions

• DRUG

No Results Yet

NCT04805866 | SUSPENDED

36 participants

Tracking Neural Synergies After Stroke.

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2021-06-09

Completion:

2024-02-21

Conditions

• Stroke

No Results Yet